NDC product
Amlodipine and Benazepril Hydrochloride
NDC 23155-920 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Key facts
| Product NDC | 23155-920 |
|---|---|
| Proprietary name | Amlodipine and Benazepril Hydrochloride |
| Nonproprietary name | Amlodipine and Benazepril Hydrochloride |
| Substances | AMLODIPINE BESYLATE, BENAZEPRIL HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA091431 |
| Pharmacologic classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE] and 2 more |
| Marketing start | Dec 19, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: